Web-Books
im Austria-Forum
Austria-Forum
Web-Books
Naturwissenschaften
Chemie
Cancer Nanotheranostics - What Have We Learnd So Far?
Seite - 117 -
  • Benutzer
  • Version
    • Vollversion
    • Textversion
  • Sprache
    • Deutsch
    • English - Englisch

Seite - 117 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Bild der Seite - 117 -

Bild der Seite - 117 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Text der Seite - 117 -

Alcantaraet al. Molecular imagingofbreast cancer Waterton, J. C., and Pylkkanen, L. (2012). Qualification of imaging biomark- ers for oncology drug development. Eur. J. Cancer 48, 409–415. doi: 10.1016/j.ejca.2011.11.037 Weissleder, R. (2006).Molecular imaging in cancer. Science 312, 1168–1171. doi: 10.1126/science.1125949 Yamaguchi, K., Abe, H., Newstead, G., Egashira, R., Nakazono, T., Imaizumi, T., et al. (2014). Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer. Breast Cancer 1–7. doi: 10.1007/s12282-013- 0512-0. [Epubaheadofprint]. Yan,C.,Wu,Y., Feng, J.,Chen,W.,Liu,X.,Hao,P., et al. (2013).Anti-alphavbeta3 antibodyguided three-steppretargetingapproachusingmagnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis. Int. J. Nanomedicine8,245–255.doi:10.2147/IJN.S38678 Zhou, Z., and Lu, Z. R. (2013). Gadolinium-based contrast agents formagnetic resonance cancer imaging.Wiley Interdiscip. Rev.Nanomed.Nanobiotechnol.5, 1–18.doi:10.1002/wnan.1198 Conflict of Interest Statement:The authors declare that the research was con- ducted in the absence of any commercial or financial relationships that could be construedasapotential conflictof interest. Received: 15 October 2014; accepted: 01 December 2014; published online: 18 December2014. Citation:AlcantaraD, LealMP,García-Bocanegra I andGarcía-MartinML (2014) Molecular imagingofbreastcancer:presentandfuturedirections.Front.Chem.2:112. doi: 10.3389/fchem.2014.00112 Thisarticlewas submitted toChemicalEngineering,a sectionof the journalFrontiers inChemistry. Copyright © 2014 Alcantara,Leal,García-BocanegraandGarcía-Martin.This isan open-access article distributedunder the terms of theCreativeCommonsAttribution License (CCBY).Theuse, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are creditedand that the original publica- tion in this journal is cited, in accordance with accepted academic practice. No use, distributionor reproduction ispermittedwhichdoesnot complywith these terms. www.frontiersin.org December2014 |Volume2 |Article112 | 117
zurück zum  Buch Cancer Nanotheranostics - What Have We Learnd So Far?"
Cancer Nanotheranostics What Have We Learnd So Far?
Titel
Cancer Nanotheranostics
Untertitel
What Have We Learnd So Far?
Autoren
João Conde
Pedro Viana Baptista
Jesús M. De La Fuente
Furong Tian
Herausgeber
Frontiers in Chemistry
Datum
2016
Sprache
englisch
Lizenz
CC BY 4.0
ISBN
978-2-88919-776-7
Abmessungen
21.0 x 27.7 cm
Seiten
132
Schlagwörter
Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
Kategorien
Naturwissenschaften Chemie
Web-Books
Bibliothek
Datenschutz
Impressum
Austria-Forum
Austria-Forum
Web-Books
Cancer Nanotheranostics